About the Company

Emedgene (now an Illumina Company) provides solutions that interpret genetic tests automatically, helping geneticists manage their growing workload faster and with higher accuracy. This is achieved with an AI engine that has learned to perform genomics research, after training with millions of data points from patient cases, databases, and the most recent genomics publications. Using Emedgene, healthcare providers will be able to provide personalized care to more patients through higher resolution rates and improved yield.